Register Now - Unlocking Longitudinal Patient-Reported Outcomes: The Untapped Value of Specialty Pharmacyocking
|Articles|May 14, 2008

Quintiles Appoints Oren Cohen to Senior Vice President, Clinical Research Strategies

Oren Cohen, MD, promoted to Quintiles' senior vice president of clinical research strategies

Research Triangle Park, NC-April 16, 2008-Quintiles Transnational (www.quintiles.com) today announced the appointment of Oren Cohen, MD, as senior vice president, clinical research strategies.
Most recently, Cohen held the position of chief medical and scientific officer. In his new role, Cohen will be responsible for evaluating and implementing new clinical research strategies, part of the company's "shape the future" objective. He also will continue to serve as managing director of Quintiles public health and government services.
Cohen is also a consulting professor of medicine at Duke University School of Medicine. He earned a medical degree from Duke University and completed his residency at New York Hospital/Cornell University Medical Center and his fellowship in infectious diseases at the National Institutes of Health. He is board-certified in internal medicine and infectious diseases and has written more than 50 scientific articles and book chapters. He is a fellow of the Infectious Diseases Society of America and serves as a reviewer for several highly respected medical journals. He has won numerous awards for his professional achievements and has presented his work at dozens of conferences around the world.


Related to this article

Where AI Leads in Trial Design—and Where Humans Still Need To
In this video interview, Claire Riches, VP of clinical solutions at Citeline, makes the case for AI as a sophisticated strategic advisor in trial design while arguing that humans must remain in the lead—especially when factors the model can't fully account for are at stake.